Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
Open Access
- 27 November 2012
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 15 (3) , 290-298
Abstract
Purpose The purpose of this study was to develop a molecular imaging technique using tracers specific for ductal carcinoma in situ (DCIS) to improve visualization and localization of DCIS during surgery. As CD44v6 is frequently expressed in DCIS, we used near-infrared fluorescently labeled CD44v6-targeting antibodies for detection of DCIS. Procedure Mice bearing orthotopically transplanted CD44v6-positive MCF10DCIS DCIS-like tumors and CD44v6-negative MDA-MB-231 control tumors were intravenously injected with IRDye800CW conjugated to CD44v6-specific antibodies or control IgGs. Noninvasive imaging was performed for 8 days postinjection, followed by intraoperative imaging. Antibody accumulation and intratumor distribution were examined. Results Maximum accumulation of CD44v6-specific antibodies was obtained 24 h postinjection. Maximum tumor-to-background ratio for MCF10DCIS tumors was 4.5 ± 0.2, compared to 1.4 ± 0.1 (control tumors, p = 0.006), and 1.7 ± 0.1 (control IgG, p = 0.014), for 8 days postinjection. Ex vivo, tumor-to-background ratios were comparable to those obtained by intraoperative imaging. Conclusions We show the applicability of noninvasive and intraoperative optical imaging of DCIS-like lesions in vivo using CD44v6-specific antibodies.Keywords
This publication has 29 references indexed in Scilit:
- A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studiesEJNMMI Research, 2012
- Immunophenotyping invasive breast cancer: paving the road for molecular imagingBMC Cancer, 2012
- Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 ImagingJournal of Nuclear Medicine, 2011
- Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting AntibodiesJournal of Nuclear Medicine, 2011
- Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistanceJournal of Clinical Investigation, 2011
- New Technologies for Human Cancer ImagingJournal of Clinical Oncology, 2008
- Safety, Pharmacokinetics, Immunogenicity, and Biodistribution of 186 Re-Labeled Humanized Monoclonal Antibody BIWA 4 (Bivatuzumab( in Patients with Early-Stage Breast CancerCancer Biotherapy and Radiopharmaceuticals, 2004
- Optical Imaging of Cancer Metastasis to Bone MarrowThe American Journal of Pathology, 2002
- The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical studyEuropean Journal of Surgical Oncology, 2001
- A CD44 variant exon 6 epitope as a prognostic indicator in breast cancerEuropean Journal of Surgical Oncology, 1996